Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
51.95
+0.52 (1.01%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $3.04 billion as of October 24, 2024. Its market cap has increased by 181.77% in one year.
Market Cap
3.04B
Enterprise Value
2.22B
1-Year Change
181.77%
Ranking
Category
Stock Price
$51.95
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $3.04B, an increase of 275.62%. That is a compound annual growth rate of 181.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 3.01B | 112.45% |
| Dec 29, 2023 | 1.42B | 75.03% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.23B |
| Envista Holdings | 3.21B |
| Amedisys | 3.18B |
| Kymera Therapeutics | 3.08B |
| Neogen | 3.03B |
| PTC Therapeutics | 3.02B |
| Iovance Biotherapeutics | 3.02B |
| MoonLake Immunotherapeutics | 3.02B |